ArticleScientific reports2026
CT-based radiomic markers to predict late-onset seizures after traumatic brain injury.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-traumatic epilepsy (PTE) is a major long-term complication of traumatic brain injury (TBI), but early risk prediction remains imprecise. Radiomics enables quantitative analysis of subtle abnormalities on non-contrast head CT (NCCT) that are not readily visible on routine imaging and may improve early risk stratification. This pilot study assessed the performance of radiomic features from acute NCCT, alone or combined with clinical variables, to predict late post-traumatic seizures (PTS) within six months of injury, an early marker of PTE. Eighty-two patients with TBI were included, and two machine-learning approaches were employed: a radiomics-only model and a clinically augmented model incorporating demographics, admission Glasgow Coma Scale (GCS), and prophylactic antiseizure medication use. Radiomics-only models showed moderate discrimination in nested cross-validation (logistic regression AUC = 0.719). Frequently selected features reflected frontal and temporal lobe asymmetry and regional heterogeneity. Adding clinical variables significantly improved performance across all models. The best model, a clinically augmented logistic regression, achieved an AUC of 0.842 with improved accuracy, precision, recall, and F1 score. Admission GCS and antiseizure prophylaxis were the most influential clinical predictors. The findings of this pilot study support NCCT-based radiomics combined with clinical data as a promising framework to be further validated for early PTE risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.